Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krisztian Homicsko

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
International Journal of Molecular Sciences|October 31, 2020
Trametinib Induces the Stabilization of a Dual <i>GNAQ</i> p.Gly48Leu- and <i>FGFR4</i> p.Cys172Gly-Mutated Uveal Melanoma. The Role of Molecular Modelling in Personalized OncologyFanny S Krebs, Camille Gérard, Alexandre Wicky, et al.
International Journal of Molecular Sciences|March 11, 2023
Response and Resistance to Trametinib in MAP2K1-Mutant Triple-Negative MelanomaFanny Seraphine Krebs, Bianca Moura, Edoardo Missiaglia, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 26, 2024
Nanoplasmonic Single-Tumoroid Microarray for Real-Time Secretion AnalysisYen-Cheng Liu, Saeid Ansaryan, Jiayi Tan, et al.
Immunity|January 11, 2023
Bispecific PD1-IL2v and anti-PD-L1 break tumor immunity resistance by enhancing stem-like tumor-reactive CD8<sup>+</sup> T cells and reprogramming macrophagesMélanie Tichet, Stephan Wullschleger, Agnieszka Chryplewicz, et al.
Nature Biomedical Engineering|June 10, 2020
High-throughput automated organoid culture via stem-cell aggregation in microcavity arraysNathalie Brandenberg, Sylke Hoehnel, Fabien Kuttler, et al.
Cancer Biology & Therapy|November 12, 2019
Durable response to palbociclib and letrozole in ovarian cancer with <i>CDKN2A</i> lossDaniele Frisone, Melinda Charrier, Sophie Clement, et al.
Nature Methods|April 30, 2026
Resolving sensitivity, specificity and signal contamination in Xenium spatial transcriptomicsMariia Bilous, Daria Buszta, Jonathan Bac, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2015
Clinical Development Strategies and Outcomes in First-in-Human Trials of Monoclonal AntibodiesDiego Tosi, Yassine Laghzali, Marie Vinches, et al.
Cancers|March 10, 2022
Safety and Efficacy of Ipilimumab plus Nivolumab and Sequential Selective Internal Radiation Therapy in Hepatic and Extrahepatic Metastatic Uveal MelanomaVeronica Aedo-Lopez, Camille L Gérard, Sarah Boughdad, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 16, 2018
Quantification of the next-generation oral anti-tumor drugs dabrafenib, trametinib, vemurafenib, cobimetinib, pazopanib, regorafenib and two metabolites in human plasma by liquid chromatography-tandem mass spectrometryEvelina Cardoso, Thomas Mercier, Anna Dorothea Wagner, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
International Journal of Molecular Sciences|October 31, 2020
Trametinib Induces the Stabilization of a Dual <i>GNAQ</i> p.Gly48Leu- and <i>FGFR4</i> p.Cys172Gly-Mutated Uveal Melanoma. The Role of Molecular Modelling in Personalized OncologyFanny S Krebs, Camille Gérard, Alexandre Wicky, et al.
International Journal of Molecular Sciences|March 11, 2023
Response and Resistance to Trametinib in MAP2K1-Mutant Triple-Negative MelanomaFanny Seraphine Krebs, Bianca Moura, Edoardo Missiaglia, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 26, 2024
Nanoplasmonic Single-Tumoroid Microarray for Real-Time Secretion AnalysisYen-Cheng Liu, Saeid Ansaryan, Jiayi Tan, et al.
Immunity|January 11, 2023
Bispecific PD1-IL2v and anti-PD-L1 break tumor immunity resistance by enhancing stem-like tumor-reactive CD8<sup>+</sup> T cells and reprogramming macrophagesMélanie Tichet, Stephan Wullschleger, Agnieszka Chryplewicz, et al.
Nature Biomedical Engineering|June 10, 2020
High-throughput automated organoid culture via stem-cell aggregation in microcavity arraysNathalie Brandenberg, Sylke Hoehnel, Fabien Kuttler, et al.
Cancer Biology & Therapy|November 12, 2019
Durable response to palbociclib and letrozole in ovarian cancer with <i>CDKN2A</i> lossDaniele Frisone, Melinda Charrier, Sophie Clement, et al.
Nature Methods|April 30, 2026
Resolving sensitivity, specificity and signal contamination in Xenium spatial transcriptomicsMariia Bilous, Daria Buszta, Jonathan Bac, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2015
Clinical Development Strategies and Outcomes in First-in-Human Trials of Monoclonal AntibodiesDiego Tosi, Yassine Laghzali, Marie Vinches, et al.
Cancers|March 10, 2022
Safety and Efficacy of Ipilimumab plus Nivolumab and Sequential Selective Internal Radiation Therapy in Hepatic and Extrahepatic Metastatic Uveal MelanomaVeronica Aedo-Lopez, Camille L Gérard, Sarah Boughdad, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 16, 2018
Quantification of the next-generation oral anti-tumor drugs dabrafenib, trametinib, vemurafenib, cobimetinib, pazopanib, regorafenib and two metabolites in human plasma by liquid chromatography-tandem mass spectrometryEvelina Cardoso, Thomas Mercier, Anna Dorothea Wagner, et al.
Pageof 6